Myelin Repair Foundation Inc
- Assets
- $1.6m
- Revenue
- $552.2k
- Investments
- $0.0
- Employees
- 1
- Location
- Saratoga, CA
- Founding
- 02/2003
- Data as of
- 06/2023
- EIN
- 03-0485196
Organization Overview
Myelin Repair Foundation Inc is located in Saratoga, CA. The organization was established in 2003. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Myelin Repair Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, Myelin Repair Foundation Inc generated $552.2k in total revenue. The organization has seen a slow decline revenue. Over the past 8 years, revenues have fallen by an average of (0.5%) each year. All expenses for the organization totaled $463.4k during the year ending 06/2023. As we would expect to see with falling revenues, expenses have declined by (6.8%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Myelin Repair Foundation Inc has awarded 17 individual grants totaling $1,194,055. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
ACCELERATING THE DEVELOPMENT OF NEW THERAPEUTICS TO PREVENT OR REPAIR DAMAGE TO MYELIN CAUSED BY MULTIPLE SCLEROSIS. MYELIN REPAIR FOUNDATION IS HELPING TO IDENTIFY BIOMARKERS OF MYELIN REPAIR FOR USE IN MYELIN REPAIR DRUG DEVELOPMENT AND CLINICAL TRIALS
Describe the Organization's Program Activity:
Part 3 - Line 4a
WE ONLY HAVE ONE AREA OF PROGRAM SERVICES AND THAT IS SCIENTIFIC RESEARCH TO BENEFIT MULTIPLE SCLEROSIS (MS) PATIENTS. CURRENTLY OUR RESEARCH IS FOCUSED ON EXPERIMENTS TO IDENTIFY BIOMARKERS TO INDICATE REPAIR OF MYELIN DAMAGED BY MS. OVER THE LAST YEAR, WE FOCUSED OUR RESEARCH ON EXTRACELLULAR VESICLES(EVS) ISOLATED FROM BLOOD. WE CURRENTLY HAVE 8 INVESTIGATIONS UNDERWAY SPREAD ACROSS EUROPE AND NORTH AMERICA. WE HAVE ENCOURAGING PRELIMINARY DATA SHOWING THAT WE CAN CLEARLY DISTINGUISH MS PATIENT EV'S FROM HEALTHY CONTROLS AND MAY BE ABLE TO IDENTIFY SUB-TYPES OF MS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Scott Johnson CEO | OfficerTrustee | 20 | $120,000 |
Andy Cates Director | Trustee | 1 | $0 |
Bobby Mehta Director | Trustee | 1 | $0 |
Jim Gidwitz Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $527,737 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $527,737 |
| Total Program Service Revenue | $0 |
| Investment income | $24,502 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $552,239 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $60,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $170,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $120,000 |
| Compensation of current officers, directors, key employees. | $9,600 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $9,325 |
| Payroll taxes | $9,394 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $4,688 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $80,446 |
| Advertising and promotion | $0 |
| Office expenses | $6,716 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $2,790 |
| All other expenses | $0 |
| Total functional expenses | $463,359 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $111,449 |
| Savings and temporary cash investments | $1,254,746 |
| Pledges and grants receivable | $168,000 |
| Accounts receivable, net | $15,988 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $1,550,183 |
| Accounts payable and accrued expenses | $623,940 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $623,940 |
| Net assets without donor restrictions | $926,243 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,550,183 |
Grants Awarded
Over the last fiscal year, Myelin Repair Foundation Inc has awarded $60,000 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
COLUMBIA UNIVERSITY PURPOSE: This study will test the diagnostic potential of extracellular vesicles (EVs) released by microglia. Microglia are resident immune cells in the central nervous system (CNS) which perform multiple functions including, immune response to local environment, communication with all CNS cells (neurons, astrocytes and oligodendrocytes) and phagocytic clearance of misfolded proteins and apoptotic or necrotic cells. EVs derived from microglia can play an important role as mediators of both pathological and reparative mechanisms in MS. Microglia are known to play key roles in both active inflammation and remyelination in MS | $50,000 |
NANOSOMIX INC PURPOSE: Nanosomix analyzed samples for MRF | $10,000 |